Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
ABSTRACT Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led to poorly defined viral prevalence rates. To address this, we analyzed seropositivity in US adults who have not previously been diagnosed with COVID-19. Individuals with characteristics that reflect the US population ( n = 11,382) and who had not …